From: CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
ADNI | Emory | |||
---|---|---|---|---|
MCI (n = 135) | AD (n = 95) | MCI (n = 51) | AD (n = 22) | |
Male (%) | 86 (64 %) | 53 (56 %) | 28 (55 %) | 6 (27 %) |
Age (S.D.), yr | 74.7 (7.6) | 74.3 (7.7) | 69.0 (7.4) | 65.6 (8.8) |
Education (S.D.), yr | 15.8 (2.9) | 14.9 (3.1) | 15.4 (2.5) | 13.9 (2.4) |
Having at least one APOE4 allele | 86 (64 %) | 67 (70 %) | 25 (49 %) | 8 (36 %) |
CSF | ||||
Aβ42 (pg/mL) | 136.7 (31.4) | 143.5 (39.9) | 129.8 (55.3) | 168.3 (104.0) |
t-Tau (pg/mL) | 122.8 (60.6) | 122.5 (57.8) | 97.7 (49.6) | 120.3 (60.0) |
p-Tau181 (pg/mL) | 42.4 (16.1) | 41.4 (19.9) | 55.6 (25.7) | 61.1 (26.2) |
FH (pg/mL) | 1568 (629) | 1750 (835) | 1594 (493) | 1692 (474) |
Z-score, log(C3) | −0.060 (0.929) | 0.061 (1.084) | −0.481 (1.031) | −0.064 (0.784) |